Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage*; D015415:Biomarkers; D001778:Blood Coagulation Disorders / Q000097:blood*; D001798:Blood Proteins / Q000032:analysis; D002417:Cattle; D003080:Cold Temperature; D005167:Factor VII / Q000032:analysis; D005168:Factor VII Deficiency / Q000097:blood; D005170:Factor X / Q000032:analysis; D005171:Factor X Deficiency / Q000097:blood; D006801:Humans; D007020:Hypoprothrombinemias / Q000097:blood; D007616:Kaolin / Q000494:pharmacology; D011498:Protein Precursors / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D011817:Rabbits; D013925:Thromboplastin / Q000592:standards*; D014812:Vitamin K / Q000494:pharmacology
D000925:Anticoagulants; D015415:Biomarkers; D001798:Blood Proteins; D011498:Protein Precursors; D014812:Vitamin K; D007616:Kaolin; C008208:acarboxyprothrombin; D005167:Factor VII; D011516:Prothrombin; D005170:Factor X; D013925:Thromboplastin